Science-in-brief: Report on the 2nd Dorothy Russell Havemeyer Foundation workshop on acute colitis of the adult horse.

1. International Equine Colitis Research Group. Science‐in‐brief: report on the Havemeyer Foundation workshop on acute colitis of the adult horse. Equine Vet J 2020;52(2):163–164.
   doi: 10.1111/evj.13223google scholar: lookup
2. Gomez DE, Dunkel B, Renaud DL, Arroyo LG, Schoster A, Kopper JJ. Survival rates and factors associated with survival and laminitis of horses with acute diarrhoea admitted to referral institutions. Equine Vet J 2024;56(5):970–981.
   doi: 10.1111/evj.14032google scholar: lookup
3. Gomez DE, Kopper JJ, Byrne DP, Renaud DL, Schoster A, Dunkel B. Treatment approaches to horses with acute diarrhoea admitted to referral institutions: a multicenter retrospective study. PLoS One 2024;19(11):e0313783.
   doi: 10.1371/journal.pone.0313783google scholar: lookup
4. Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology 2024;166(1):44–58.
   doi: 10.1053/j.gastro.2023.09.019google scholar: lookup
5. Mirsepasi‐Lauridsen HC, Vallance BA, Krogfelt KA, Petersen AM. Escherichia coli pathobionts associated with inflammatory bowel disease. Clin Microbiol Rev 2019;32(2):1–16.
   doi: 10.1128/cmr.00060-18google scholar: lookup
6. Mansour S, Asrar T, Elhenawy W. The multifaceted virulence of adherent‐invasive Escherichia coli. Gut Microbes 2023;15(1):2172669.
   doi: 10.1080/19490976.2023.2172669google scholar: lookup
7. Masaadeh AH, Eletrebi M, Parajuli B, De Jager N, Bosch DE. Human colitis‐associated colorectal carcinoma progression is accompanied by dysbiosis with enriched pathobionts. Gut Microbes 2025;17(1):2479774.
   doi: 10.1080/19490976.2025.2479774google scholar: lookup
8. Yamamoto Y, Kamiya T, Yano M, Huyen VT, Oishi M, Nishio M. Oral microbial profile analysis in patients with oral and pharyngeal cancer reveals that tumoral fusobacterium nucleatum promotes oral cancer progression by activating YAP. Microorganisms 2023;11(12):2957.
   doi: 10.3390/microorganisms11122957google scholar: lookup
9. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 2016;533(7604):543–546.
   doi: 10.1038/nature17645google scholar: lookup
10. Lau JT, Whelan FJ, Herath I, Lee CH, Collins SM, Bercik P. Capturing the diversity of the human gut microbiota through culture‐enriched molecular profiling. Genome Med 2016;8(1):72.
    doi: 10.1186/s13073-016-0327-7google scholar: lookup
11. Whelan FJ, Waddell B, Syed SA, Shekarriz S, Rabin HR, Parkins MD. Culture‐enriched metagenomic sequencing enables in‐depth profiling of the cystic fibrosis lung microbiota. Nat Microbiol 2020;5(2):379–390.
    doi: 10.1038/s41564-019-0643-ygoogle scholar: lookup
12. Diop K, Mbaye B, Nili S, Filin A, Benlaifaoui M, Malo J. Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors. Gut Pathog 2025;17(1):21.
    doi: 10.1186/s13099-025-00694-4google scholar: lookup
13. Shekarriz S, Szamosi JC, Whelan FJ, Lau JT, Libertucci J, Rossi L. Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise. Nat Commun 2025;16(1):3469.
    doi: 10.1038/s41467-025-58673-xgoogle scholar: lookup
14. Armetta J, Li SS, Vaaben TH, Vazquez‐Uribe R, Sommer MOA. Metagenome‐guided culturomics for the targeted enrichment of gut microbes. Nat Commun 2025;16(1):663.
    doi: 10.1038/s41467-024-55668-ygoogle scholar: lookup
15. Tkach VV, Greiman SE. Transmission biology, host associations, distribution and molecular diagnostics of Neorickettsia. In: Thomas S, editor. Rickettsiales: biology, molecular biology, epidemiology, and vaccine development. Cham: Springer International Publishing; 2016.
    doi: 10.1007/978-3-319-46859-4_15google scholar: lookup
16. Greiman SE, Rikihisa Y, Cain J, Vaughan JA, Tkach VV. Germs within worms: localization of Neorickettsia sp. within life cycle stages of the digenean Plagiorchis elegans. Appl Environ Microbiol 2016;82(8):2356–2362.
    doi: 10.1128/aem.04098-15google scholar: lookup
17. McNulty SN, Tort JF, Rinaldi G, Fischer K, Rosa BA, Smircich P. Genomes of Fasciola hepatica from the Americas reveal colonization with Neorickettsia endobacteria related to the agents of Potomac horse and human Sennetsu fevers. PLoS Genet 2017;13(1):e1006537.
    doi: 10.1371/journal.pgen.1006537google scholar: lookup
18. Greiman SE, Tkach VV, Pulis E, Fayton TJ, Curran SS. Large scale screening of digeneans for Neorickettsia endosymbionts using real‐time PCR reveals new Neorickettsia genotypes, host associations and geographic records. PLoS One 2014;9(6):e98453.
    doi: 10.1371/journal.pone.0098453google scholar: lookup
19. Teymournejad O, Lin M, Bekebrede H, Kamr A, Toribio RE, Arroyo LG. Isolation and molecular analysis of a novel Neorickettsia species that causes Potomac horse fever. MBio 2020;11(1):1–19.
    doi: 10.1128/mbio.03429-19google scholar: lookup
20. Greiman SE, Tkach M, Vaughan JA, Tkach VV. Laboratory maintenance of the bacterial endosymbiont, Neorickettsia sp., through the life cycle of a digenean, Plagiorchis elegans. Exp Parasitol 2015;157:78–83.
    doi: 10.1016/j.exppara.2015.06.015google scholar: lookup
21. Kilcoyne I, Magdesian KG, Guerra M, Dechant JE, Spier SJ, Kass PH. Prevalence of and risk factors associated with Salmonella shedding among equids presented to a veterinary teaching hospital for colic (2013–2018). Equine Vet J 2023;55(3):446–455.
    doi: 10.1111/evj.13864google scholar: lookup
22. García JA, Navarro MA, Fresneda K, Uzal FA. Clostridium piliforme infection (Tyzzer disease) in horses: retrospective study of 25 cases and literature review. J Vet Diagn Invest 2022;34(3):421–428.
    doi: 10.1177/10406387211031213google scholar: lookup
23. Love S, Murphy D, Mellor D. Pathogenicity of cyathostome infection. Vet Parasitol 1999;85(2–3):113–121.
    doi: 10.1016/s0304-4017(99)00092-8google scholar: lookup
24. Lawson AL, Malalana F, Mair TS. Larval cyathostominosis: clinicopathological data and treatment outcomes of 38 hospitalised horses (2009–2020). Equine Vet Educ 2023;35(8):424–435.
    doi: 10.1111/eve.13782google scholar: lookup
25. Peregrine AS, McEwen B, Bienzle D, Koch TG, Weese JS. Larval cyathostominosis in horses in Ontario: an emerging disease?. Can Vet J 2006;47(1):80–82.
26. Smets K, Shaw DJ, Deprez P, Vercruysse J. Diagnosis of larval cyathostominosis in horses in Belgium. Vet Rec 1999;144(24):665–668.
    doi: 10.1136/vr.144.24.665google scholar: lookup
27. Manrique‐Caballero CL, Del Rio‐Pertuz G, Gomez H. Sepsis‐associated acute kidney injury. Crit Care Clin 2021;37(2):279–301.
    doi: 10.1016/j.ccc.2020.11.010google scholar: lookup
28. Sun B, Lei M, Zhang J, Kang H, Liu H, Zhou F. Acute lung injury caused by sepsis: how does it happen?. Front Med (Lausanne) 2023;10:1289194.
    doi: 10.3389/fmed.2023.1289194google scholar: lookup
29. Elliott J, Bailey SR. A review of cellular and molecular mechanisms in endocrinopathic, sepsis‐related and supporting limb equine laminitis. Equine Vet J 2023;55(3):350–375.
    doi: 10.1111/evj.13933google scholar: lookup
30. Leise BS, Fugler LA. Laminitis updates: sepsis/systemic inflammatory response syndrome‐associated laminitis. Vet Clin North Am Equine Pract 2021;37(3):639–656.
    doi: 10.1016/j.cveq.2021.08.003google scholar: lookup
31. Medina‐Torres CE, van Eps AW, Nielsen LK, Hodson MP. A liquid chromatography‐tandem mass spectrometry‐based investigation of the lamellar interstitial metabolome in healthy horses and during experimental laminitis induction. Vet J 2015;206(2):161–169.
    doi: 10.1016/j.tvjl.2015.07.031google scholar: lookup
32. Medina‐Torres CE, Underwood C, Pollitt CC, Castro‐Olivera EM, Hodson MP, Richardson DW. Microdialysis measurements of lamellar perfusion and energy metabolism during the development of laminitis in the oligofructose model. Equine Vet J 2016;48(2):246–252.
    doi: 10.1111/evj.12417google scholar: lookup
33. Stokes SM, Bertin FR, Stefanovski D, Poulsen L, Belknap JK, Medina‐Torres CE. The effect of continuous digital hypothermia on lamellar energy metabolism and perfusion during laminitis development in two experimental models. Equine Vet J 2020;52(4):585–592.
    doi: 10.1111/evj.13215google scholar: lookup
34. Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, Moore RM. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res 2004;65(5):578–585.
    doi: 10.2460/ajvr.2004.65.578google scholar: lookup
35. Catunda APN, Alves GES, Paes Leme FO, Carvalho AM, Leise BS, Johnson PJ. Apoptosis in epithelial cells and its correlation with leukocyte accumulation in lamellar tissue from horses subjected to experimental sepsis‐associated laminitis. Res Vet Sci 2021;136:318–323.
    doi: 10.1016/j.rvsc.2021.03.009google scholar: lookup
36. Loftus JP, Johnson PJ, Belknap JK, Pettigrew A, Black SJ. Leukocyte‐derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol 2009;129(3–4):221–230.
    doi: 10.1016/j.vetimm.2008.11.003google scholar: lookup
37. Visser MB, Pollitt CC. The timeline of metalloprotease events during oligofructose induced equine laminitis development. Equine Vet J 2012;44(1):88–93.
    doi: 10.1111/j.2042-3306.2011.00393.xgoogle scholar: lookup
38. Arulkumaran N, Deutschman CS, Pinsky MR, Zuckerbraun B, Schumacker PT, Gomez H. Mitochondrial function in sepsis. Shock 2016;45(3):271–281.
    doi: 10.1097/shk.0000000000000463google scholar: lookup
39. van Eps AW, Pollitt CC. Equine laminitis induced with oligofructose. Equine Vet J 2006;38(3):203–208.
    doi: 10.2746/042516406776866327google scholar: lookup
40. Dern K, Burns TA, Watts MR, van Eps AW, Belknap JK. Influence of digital hypothermia on lamellar events related to IL‐6/gp130 signalling in equine sepsis‐related laminitis. Equine Vet J 2020;52(3):441–448.
    doi: 10.1111/evj.13184google scholar: lookup
41. Kullmann A, Holcombe SJ, Hurcombe SD, Roessner HA, Hauptman JG, Geor RJ. Prophylactic digital cryotherapy is associated with decreased incidence of laminitis in horses diagnosed with colitis. Equine Vet J 2014;46(5):554–559.
    doi: 10.1111/evj.12156google scholar: lookup
42. Gomez D, Toribio R, Caddey B, Costa M, Vijan S, Dembek K. Longitudinal effects of oral administration of antimicrobial drugs on fecal microbiota of horses. J Vet Intern Med 2023;37(6):2562–2572.
    doi: 10.1111/jvim.16853google scholar: lookup
43. Gomez DE, Weese JS. Antimicrobial prophylaxis, metaphylaxis, and the treatment of immunocompromised patients. Antimicrobial therapy in veterinary medicine. Hoboken, NJ: Wiley; 2024. p. 487–511.
    doi: 10.1002/9781119654629.ch24google scholar: lookup
44. Boucher L, Leduc L, Leclère M, Costa MC. Current understanding of equine gut dysbiosis and microbiota manipulation techniques: comparison with current knowledge in other species. Animals (Basel) 2024;14(5):758.
    doi: 10.3390/ani14050758google scholar: lookup
45. Quattrini C, Bozorgmanesh R, Egli P, Magdesian KG. Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses‐111 cases (2013–2018). Open Vet J 2023;13(9):1135–1140.
    doi: 10.5455/ovj.2023.v13.i9.9google scholar: lookup
46. Arantes JA, Di Pietro R, Ratté M, Arroyo LG, Leclère M, Costa MC. Changes in bacterial viability after preparation and storage of fecal microbiota transplantation solution using equine feces. PeerJ 2025;13:e18860.
    doi: 10.7717/peerj.18860google scholar: lookup
47. FAO/WHO. Guidelines for the evaluation of probiotics in food. London, Ontario, Canada: Food and Agriculture Organization of the United Nations; 2002.
48. Berreta A, Burbick CR, Alexander T, Kogan C, Kopper JJ. Microbial variability of commercial equine probiotics. J Equine Vet Sci 2021;106:103728.
    doi: 10.1016/j.jevs.2021.103728google scholar: lookup
49. Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J 2011;52(1):43–46.
50. Berreta A, Kopper J. Equine probiotics—what are they, where are we and where do we need to go?. J Equine Vet Sci 2022;115:104037.
    doi: 10.1016/j.jevs.2022.104037google scholar: lookup
51. Baumgardner RM, Berreta A, Kopper JJ. Evaluation of commercial probiotics for antimicrobial resistance genes. Can Vet J 2021;62(4):379–383.
52. Berreta A, Baumgardner RM, Kopper JJ. Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes. BMC Res Notes 2020;13(1):275.
    doi: 10.1186/s13104-020-05114-1google scholar: lookup

Citations